Multifocal Contact Lenses Fitting Methods Comparison
Biofinity Multifocal Contact Lenses Fitting Methods Comparison
1 other identifier
interventional
25
1 country
1
Brief Summary
The purpose of this study was to compare the clinical performance of two fitting approaches for multifocal contact lenses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 9, 2023
CompletedFirst Posted
Study publicly available on registry
February 21, 2023
CompletedResults Posted
Study results publicly available
January 10, 2024
CompletedJanuary 10, 2024
February 1, 2023
2 months
February 9, 2023
November 29, 2023
December 18, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Overall Vision Satisfaction
Overall vision satisfaction for each lens was measured on a 0-100 point Visual Analog Scale (VAS), where 0=Extremely Unsatisfied and 100=Extremely Satisfied
One week
Overall Lens Preference
Participants selected their preferred lens fitting approach from options - 'Control', 'Test', or 'No Preference'
Two weeks
Secondary Outcomes (2)
Overall Binocular Visual Acuity Index
One week
Number of Contact Lenses
One week
Study Arms (2)
Control Lenses, then Test Lenses
EXPERIMENTALParticipants wore the Control Lenses for 1 week, then crossed over to the Test Lenses for 1 week.
Test Lenses, then Control Lens
EXPERIMENTALParticipants wore the Test Lenses for 1 week, then crossed over to the Control Lenses for 1 week.
Interventions
Daily wear multifocal lenses for 1 week
Daily wear multifocal lenses for 1 week
Eligibility Criteria
You may qualify if:
- At least 40 years old;
- Have read and understood the Participant Information Sheet;
- Have read, signed and dated the Informed Consent;
- Best corrected visual acuity of at least 20/25 in each eye;
- Have normal eyes with the exception of the need for visual correction;
- Current multifocal contact lens wearer;
- Spectacle refraction:
- Distance: Sphere: -6.00D to + 4.00D Astigmatism: 0.00D to -0.75D Near Addition: Established Presbyopes: +1.50D \& +1.75D
- Be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule.
You may not qualify if:
- Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
- Use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator;
- Monocular participants (only one eye with functional vision) or participants fit with only one lens;
- Any moderate or severe ocular condition observed during the slit-lamp examination at the enrolment visit;
- History of herpetic keratitis, ocular surgery or irregular cornea;
- Known pregnancy or lactation during the study period;
- Enrolment of the investigator or his/her staff, family members of the investigator, family members of the investigator's staff, or individuals living in the households of these individuals.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ocular Technology Group - International
London, SW1E 6AU, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Percy Lazon de la Jara BOptom PhD
- Organization
- CooperVision Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Michel Guillon, PhD, FCOptom
Ocular Technology Group - International
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2023
First Posted
February 21, 2023
Study Start
October 11, 2022
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
January 10, 2024
Results First Posted
January 10, 2024
Record last verified: 2023-02